
Sikandar Khan MD
Critical Care Medicine, Pulmonology
Cleveland Clinic Florida
Join to View Full Profile
2950 Cleveland Clinic BoulevardWeston, FL 33331
Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sikandar Khan is a Critical Care Medicine specialist based in Weston, FL, with subspecialties in Critical Care Medicine and Pulmonology. He completed his medical education at the AUC School of Medicine and further trained at Cleveland Clinic Florida, where he completed his residency and fellowship. He also served as a Chief Resident at NCH Healthcare System. Dr. Khan is currently a Pulmonary and Critical Care Medicine Fellow at Cleveland Clinic Florida. His research contributions include several published case reports and studies in recognized medical journals.
Education & Training
- Cleveland Clinic Foundation/Florida WestonFellowship, Pulmonary Disease and Critical Care Medicine, 2023
- NCH Healthcare SystemChief Residency, Internal Medicine, 2022 - 2023
- Cleveland Clinic Foundation/Florida WestonResidency, Internal Medicine, 2019 - 2022
- American University of the Caribbean School of MedicineClass of 2019
Certifications & Licensure
- FL State Medical License 2019 - 2026
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Atypical Presentation of Ziprasidone-Induced Neuroleptic Malignant Syndrome: A Case Report.John Allonce, Sikandar Khan, Brian Pulford
Journal of Investigative Medicine High Impact Case Reports. 2024-07-24 - 6 citationsPotential clinical complications of Orise™ gel use, a new submucosal lifting agent: experience from a tertiary care center and review of the literature.Yasar Colak, Badar Hasan, Kanwarpreet Tandon, Sikandar Khan, Vaibhav Wadhwa
Annals of Gastroenterology. 2022-06-02 - 19 citationsUstekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancy.Badar Hasan, Kanwarpreet Singh Tandon, Rafael Miret, Sikandar Khan, Amir Riaz
Journal of Gastroenterology and Hepatology. 2022-06-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: